Healthcare
Seed Capital sells EpiTherapeutics to Gilead for $65m
Sale brings Seed Capital's total exit value to DKK 3bn for past year
Cathay leads €30m funding round for Echosens
First investment for firm's latest midcap vehicle
VC-backed Biocartis lists with €450m market cap
Biocartis raises €100m in offering
CBPE scores 22x return on IDIS sale
CBPE has sold IDIS to Clinigen for ТЃ225m, generating a 22x return
Foresight backs £2.6m MBO of Specac
Foresight introduces Kevin O'Donovan as company's new chair
Industrifonden in $14m round for Bonesupport
Round was led by unnamed Scandinavian pension fund
Vesalius Biocapital leads €6.2m Omeicos series-A
High-Tech Gründerfonds, IBB and KfW Bank also take part
Ardian-backed Anios acquires Deren
Deal marks first foreign acquisition by Anios since 2013 MBO
MVM leads €10m round for Onbone
Funding round brings new CEO on board
HTGF backs Sonormed
Medtech company treats tinnitus with Tinnitracks therapy
HBM Partners backs APR
Swiss firm holds 56% stake alongside Bright Technology Fund
Apposite scores 3.5x on By the Bridge sale
Apposite acquired the company in 2006
Sofinnova's Cerenis in €226m IPO
French biotech company raises €53.4m as part of listing
Forbion et al. back Rigontec's €4.8m series-A
Total invested in round comes to €14.25m
Vaaka Partners builds Fysios platform
New physiotherapy chain incorporates seven businesses
Ace and Auriga in €2.6m round for Pherecydes Pharma
Business angels also take part in round
VC-backed Canbex sold to Ipsen
Ipsen pays тЌ6m upfront with further тЌ90m expected
Siparex et al. invest €1m in Calixar
Biotech company's existing investors all took part in round
FSN exits Teres
Surgical group sold to Wallenberg-owned medical group Aleris
Sunstone leads €8.7m Prexton Therapeutics round
Ysios Capital and MS Ventures also take part in series-A
Kernel invests in Cirdan
Company already backed by development agency Invest NI
HTGF backs Immunservice's series-C
GP previously injected seed capital in 2008
Gimv et al. sell ActoGenix for $60m
Transaction includes $30m worth of Intrexon stock
Mister Spex bolts on Lensit.no
VC-backed firm uses Goldman Sachs funding to finance deal